AIRWAY/ PLAIRWY00017 /
| 2024-06-11 3:28:28 PM | Chg. +0.01 | Volume | Bid3:37:25 PM | Ask3:37:25 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.27PLN | +2.28% | 185,440 Turnover: 48,882.01 |
0.26Bid Size: 2,000 | 0.27Ask Size: 9,384 | 0.27 | 0.25 |
GlobeNewswire
3:00 PM
Monaghan Medical Corporation and Captis Continue to Partner to Improve Patient Outcomes
GlobeNewswire
06-10
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep A...
GlobeNewswire
06-06
4DMT Presents Positive Interim Data from Phase 1/2 AEROW Clinical Trial of Aerosolized 4D-710 for Mo...
GlobeNewswire
06-04
BioVersys Awarded Non-Dilutive Funding From CF AMR Syndicate Collaborative Discovery Programme
GlobeNewswire
05-30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire
05-30
Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patie...
GlobeNewswire
05-23
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Preval...
GlobeNewswire
05-23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
05-21
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the Americ...
GlobeNewswire
05-16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
05-16
Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the...
GlobeNewswire
05-16
Chiesi to Present New Data Showcasing Depth of Respiratory Leadership at the American Thoracic Socie...
GlobeNewswire
05-15
Upstream Bio to Present Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asth...
GlobeNewswire
05-15
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
GlobeNewswire
05-14
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
05-14
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
05-13
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...
GlobeNewswire
05-10
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meetin...
GlobeNewswire
05-09
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Ni...
GlobeNewswire
05-09
ASLAN Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
